EXCITING PRESS

InMode (INMD) featured on Mad Money with Jim Cramer

InMode (INMD) featured on Mad Money with Jim Cramer

Mad Money host Jim Cramer answers callers’ stock questions during the Lightning Round, including InMode.

Watch the clip here.

Can Medical Aesthetics Firm InMode Keep Its Picture-Perfect Growth Streak Alive?

Can Medical Aesthetics Firm InMode Keep Its Picture-Perfect Growth Streak Alive?

Investor’s Business Daily reporter Allison Gatlin writes that “InMode stock is looking picture perfect” as the stock (Nasdaq: INMD) has managed to stay at the top of the IBD 50. So, what’s driving the outperformance? “Aesthetics, in general, are growing because of a variety of factors,” Needham analyst Mike Matson told Investor’s Business Daily, noting social media, the Zoom culture and an aging population have played a role in the recent medical aesthetics boom. InMode’s technology leads to “better results with less invasive treatment,” Matson added, “that technology is unique and that’s what’s been the primary driver.”

Read the full article here.

Charts suggest InMode stock is worth buying into weakness, says Jim Cramer

Charts suggest InMode stock is worth buying into weakness, says Jim Cramer

CNBC’s Mad Money host Jim Cramer and Bob Lang review four growth stocks, including shares of medical technology company InMode.

Read the full article here.

3 COVID Stocks That Might Double Soon

3 COVID Stocks That Might Double Soon

Motley Fool author, Patrick Bafuma, thinks InMode (NASDAQ: INMD) will close out 2021 with a bang. As the world slowly returns to normal and consumers seek treatments that they had delayed due to COVID-19, the aesthetics market is sure to heat up and is expected to grow, so there is plenty of room to run for InMode. “InMode (sic) demand is strong. Over one-third of the new patients coming in have never had any aesthetics procedure done before, “says InMode chief medical officer Dr. Spero Theodorou, “Waiting lists are about a month out.” With many of us either in the house or masked up since March 2020, Bafuma expects continued growth for InMode.

Read the article here.

 Seeking Alpha Logo

InMode: Taking Notes From Align Technologies

A new article in Seeking Alpha, by featured contributor Eric Groovenhoff, notes that “InMode has consistently executed its business flawlessly with exceptional margins,” under the guidance of its dedicated management with a long-term outlook. In conversation with Moshe Mizrahy, co-founder and CEO, he talked about how the technology operates today, and the direction the company can go over the next several years, “positioning it as a bullish stock, even at its current premium price.”

Read the article here.

How can we help?

Please select a topic below related to your inquiry.

Find a clinic
Questions about treatments
Questions about our technologies or workstations
General inquiries email or call 1.855.411.2639

GET STARTED

Which technology is right for you?

Contact Us
Contact Us

Contact Us